By Jewish Business News On Sunday, August 20th, 2017

Teva Launches Generic Testosterone Boost Treatment

Teva Pharmaceutical Industries Ltd. today announced the launch of generic Axiron (testosterone) topical solution CIII, 30 mg/1.5 mL, in the US. Testosterone topical solution CIII is a prescription medicine used More...

By Nir Eyal On Sunday, August 6th, 2017

Teva Crashes 18% on Tel Aviv Trading Opens, Loses Third of Its Value in Two Days

  Teva Pharmaceutical Industries Ltd. opened Sunday morning with another hit. The Israeli giant plummeted 17.6% down on the Tel Aviv Stock Exchange after losing 17.79% on Thursday. The company announced on More...

By Omri Cohen On Thursday, August 3rd, 2017

Drama in Teva: Cutting 7,000 Jobs in 45 Countries ; Share Price Plunges

Teva Pharmaceutical Industries announced today that it is cutting 7,000 jobs in 45 countries and will close 15 factories by the end of 2018, following the publication of the financial results of the company for More...

By Jewish Business News On Monday, July 24th, 2017

Israeli Biomed NeuroDerm Sells for $1.1 Billion in Cash to Japanese Mitsubishi Tanabe

In the largest biomed acquisition in Israel, and one of the largest deals in the Israeli economy in general, biomed NeuroDerm is sold for $ 1.1 billion in cash to Japanese Mitsubishi Tanabe Pharma. NeuroDerm is More...

By Jewish Business News On Sunday, May 7th, 2017

Teva and Active Biotech Announce CONCERTO Trial of Laquinimod Trial Fails

   Teva Pharmaceutical Industries Ltd. and its partner Active Biotech reported on Friday that the CONCERTO trial of its ethical drug laquinimod in patients with relapsing-remitting multiple sclerosis (RRMS) More...

By Jewish Business News On Thursday, March 30th, 2017

Israeli BiondVax to Build Facility for Commercial Production of Universal Flu Vaccine

BiondVax Pharmaceuticals Ltd. today announced that the Israel Investment Center, a unit of the Government of Israel’s Ministry of Economy and Industry, approved a grant representing 20 percent of a NIS 20 million More...

By Jewish Business News On Thursday, March 2nd, 2017

Israel’s Panaxia, Ultra Health Launched U.S First Medical Cannabis Production Facility

Israeli pharmaceutical company Panaxia Pharmaceuticals Industries Ltd, specializing in medical cannabis R&D and manufacturing, and Ultra Health, New Mexico’s No. 1 cannabis company with a nationwide presence, More...

By Nir Eyal On Tuesday, February 28th, 2017

Perrigo Shares Down 10% After Company Reports Loss, Sells Tysabri Drug Royalties

  Perrigo announced on Monday that it had signed a definitive agreement to divest its rights to the royalty stream from the global net sales of the multiple sclerosis drug Tysabri (natalizumab) to RPI Finance More...

Grass, Sensi Seeds, holand
By Jewish Business News On Wednesday, February 22nd, 2017

Kalytera Therapeutics Buys Israeli Cannabis Talent Biotech

  Canadian company Kalytera Therapeutics, Inc. has acquired Israeli medical cannabis developer Talent Biotech. Talent is a privately held company evaluating the use of CBD to prevent and treat Graft versus More...

By Viva Sarah Press On Friday, February 17th, 2017

5 Ways Israel Is Dominating the Medical Cannabis World

Israeli Medical cannabis paraphernalia on display at CannaTech 2016/ Photo courtesy   Israel has been the cutting edge of medical cannabis research for decades, and has made some of the groundbreaking discoveries More...


Delivered by FeedBurner